{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02553603","recordId":"NCT02553603","peptideSlug":"tesamorelin","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02553603-tesamorelin/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02553603.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02553603.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2015-09-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2015-09-16","publishedAt":"2026-08-23","recordId":"NCT02553603","recordSha256":"da5b8baff648b7e7db741a9cc0113829f096399976b033ab74dd09eb7d18f537","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02553603?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2016-05-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2016-05-10","publishedAt":"2026-08-23","recordId":"NCT02553603","recordSha256":"4d3798e06c6d8ae75cfd1094d4d68b84c9b33178966b71e0367de99303b0049d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02553603?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Eligibility","Outcome Measures","Oversight","Sponsor/Collaborators","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-08-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2017-08-15","publishedAt":"2026-08-23","recordId":"NCT02553603","recordSha256":"f1329b64f05bc074cc4ce63fd5fed2b32d4fc3adea517eacd469c54bba42e67a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02553603?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Eligibility","Study Description","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2018-02-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2018-02-14","publishedAt":"2026-08-23","recordId":"NCT02553603","recordSha256":"09debcfe7d47b3ecf9b0f84086a8df59b93d04fef6a9e76701ea3791134bd69e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02553603?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2018-07-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2018-07-09","publishedAt":"2026-08-23","recordId":"NCT02553603","recordSha256":"daa2f5785230ed956b31fdc3890de6ce71c1674364ed2c551d463ac299a05fef","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02553603?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2019-04-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2019-04-16","publishedAt":"2026-08-23","recordId":"NCT02553603","recordSha256":"37255e5525e0af29b785dbb8aab56c6769a09a9043897eddce346cd01c5dc431","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02553603?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2019-11-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2019-11-01","publishedAt":"2026-08-23","recordId":"NCT02553603","recordSha256":"c4053ffc6caad15f2a676dff3d199052cff489612a7cecca1dff586b1cacdc43","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02553603?a=7&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"e4328a2865c8a49ebc95b9e1ae836223ee8e8c30b7872b04bb8bf83711e186bf"}}